OCDX News and Press, Ortho Clinical Diagnostics plc From 05/21/21

Ortho Clinical Diagnostics (OCDX) announces the launch of its quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.Both tests help in differentiating the cause of antibodies against SARS-CoV-2 and are processed on Ortho's VITROS Sys...

Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response Canada NewsWire - Ortho is the only company that offers laboratories in the U...

RARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to present in two upcoming investor conferences: ...

The FDA has issued a safety announcement that the public should not use the results of SARS-CoV-2 antibody tests to determine immunity or protection against COVID-19.The tests should only be used to determine if someone has been exposed to SARS-CoV-2 in the past and developed an immune respon...

Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive Authorization by Health Canada Canada NewsWire - Ortho's VITROS ® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen te...

Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2021 Earnings Conference Call May 05, 2021, 05:00 PM ET Company Participants John Sanders - VP of Finance, Treasurer, and Head of IR Chris Smith - Chairman and CEO Joe Busky - CFO Mike Iskra - EVP, Commercial Excellence and Strategy Conference...

The following slide deck was published by Ortho Clinical Diagnostics Holdings plc in conjunction with their 2021 Q1 earnings call. For further details see: Ortho Clinical Diagnostics Holdings plc 2021 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Q1 2021 Earnings Call May 05, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2...

Ortho Clinical Diagnostics (OCDX): Q1 Non-GAAP EPS of $0.26 beats by $0.10; GAAP EPS of -$0.19 beats by $0.09.Revenue of $499.3M (+23.5% Y/Y) beats by $21.77M.Press Release For further details see: Ortho Clinical Diagnostics EPS beats by $0.10, beats on revenue

RARITAN, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the first quarter ended April 4, 2021. Highlights Firs...